22-43129222-G-A
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001197.5(BIK):c.400G>A(p.Glu134Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000517 in 1,604,712 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001197.5 missense
Scores
Clinical Significance
Conservation
Publications
- prostate cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001197.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| BIK | NM_001197.5 | MANE Select | c.400G>A | p.Glu134Lys | missense | Exon 5 of 5 | NP_001188.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| BIK | ENST00000216115.3 | TSL:1 MANE Select | c.400G>A | p.Glu134Lys | missense | Exon 5 of 5 | ENSP00000216115.2 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152042Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000129 AC: 31AN: 240912 AF XY: 0.000114 show subpopulations
GnomAD4 exome AF: 0.0000441 AC: 64AN: 1452552Hom.: 0 Cov.: 35 AF XY: 0.0000553 AC XY: 40AN XY: 722952 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000125 AC: 19AN: 152160Hom.: 0 Cov.: 33 AF XY: 0.000148 AC XY: 11AN XY: 74398 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.400G>A (p.E134K) alteration is located in exon 5 (coding exon 4) of the BIK gene. This alteration results from a G to A substitution at nucleotide position 400, causing the glutamic acid (E) at amino acid position 134 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at